Literature DB >> 29928326

Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.

Zhongcheng Zhu1.   

Abstract

The active ingredients of natural plants are important sources of antitumor agents. Miltirone is a major effective ingredient in traditional Chinese medicine and it is considered to have anti-infection and immunosuppressive activities. Clinically, it is often used for the treatment of arthritis and immune diseases. The effect of miltirone on cisplatin-resistant lung cancer cells has not been investigated to date. The present study aimed to examine the anticancer effect of miltirone in cisplatin-resistant lung cancer cells. Treatment with miltirone suppressed cell viability and induced apoptosis in HCC827 and A549 platinum-resistant lung cancer cells. It was also revealed that miltirone increased caspase-3/8 activity as well as B-cell lymphoma 2-associated X-protein, apoptosis-inducing factor (AIF), p53 and poly(ADP-ribose) polymerase (PARP) protein expression, whereas it inhibited mitochondrial reactive oxygen species (ROS) generation and matrix metalloproteinase (MMP)-2/9 protein expression in HCC827 and A549 platinum-resistant lung cancer cells. The results of the present study demonstrated that miltirone induces apoptosis in cisplatin-resistant lung cancer cells through ROS-p53, AIF, PARP and MMP2/9 signaling pathways.

Entities:  

Keywords:  cisplatin resistance; lung cancer cells; miltirone; p53

Year:  2018        PMID: 29928326      PMCID: PMC6004674          DOI: 10.3892/ol.2018.8440

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer--response.

Authors:  Robert J G Cardnell; Lauren A Byers
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

2.  Miltirone Induces G2/M Cell Cycle Arrest and Apoptosis in CCRF-CEM Acute Lymphoblastic Leukemia Cells.

Authors:  Ching-Fen Wu; Thomas Efferth
Journal:  J Nat Prod       Date:  2015-06-02       Impact factor: 4.050

3.  PARP inhibitor activates the intrinsic pathway of apoptosis in primary lung cancer cells.

Authors:  Nupur N Gangopadhyay; James D Luketich; Amy Opest; Rodney Landreneau; Matthew J Schuchert
Journal:  Cancer Invest       Date:  2014-06-04       Impact factor: 2.176

4.  Miltirone induced mitochondrial dysfunction and ROS-dependent apoptosis in colon cancer cells.

Authors:  Lin Wang; Tao Hu; Jing Shen; Lin Zhang; Long-Fei Li; Ruby Lok-Yi Chan; Ming-Xing Li; William Ka-Kei Wu; Chi-Hin Cho
Journal:  Life Sci       Date:  2016-03-09       Impact factor: 5.037

5.  Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.

Authors:  Masaru Matsumoto; Wataru Nakajima; Masahiro Seike; Akihiko Gemma; Nobuyuki Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2016-03-18       Impact factor: 3.575

6.  HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells.

Authors:  Jin-Tang Chen; Chih-Yang Huang; Yung-Yen Chiang; Wen-Heng Chen; Shiow-Her Chiou; Chih-Yi Chen; Kuan-Chih Chow
Journal:  Am J Respir Cell Mol Biol       Date:  2007-12-20       Impact factor: 6.914

7.  High COL4A3 expression correlates with poor prognosis after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Authors:  Cheng-Ping Jiang; Bi-Hua Wu; Shao-Ping Chen; Mao-Yong Fu; Ming Yang; Fu Liu; Bai-Qiang Wang
Journal:  Tumour Biol       Date:  2012-10-30

8.  Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.

Authors:  Robert J Cardnell; Ying Feng; Seema Mukherjee; Lixia Diao; Pan Tong; C Allison Stewart; Fatemeh Masrorpour; YouHong Fan; Monique Nilsson; Yuqiao Shen; John V Heymach; Jing Wang; Lauren A Byers
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

9.  Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL.

Authors:  A Meijer; F A E Kruyt; A G J van der Zee; H Hollema; P Le; K A ten Hoor; G M M Groothuis; W J Quax; E G E de Vries; S de Jong
Journal:  Br J Cancer       Date:  2013-10-17       Impact factor: 7.640

10.  Miltirone exhibits antileukemic activity by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction pathways.

Authors:  Ling Zhou; Lifeng Jiang; Maolei Xu; Qun Liu; Ning Gao; Ping Li; E-Hu Liu
Journal:  Sci Rep       Date:  2016-02-05       Impact factor: 4.379

View more
  3 in total

1.  Miltirone Attenuates Reactive Oxygen Species-Dependent Neuronal Apoptosis in MPP+-Induced Cell Model of Parkinson's Disease Through Regulating the PI3K/Akt Pathway.

Authors:  Huiqiong Feng; Fuqiang Xi
Journal:  Neurochem Res       Date:  2022-07-09       Impact factor: 4.414

2.  Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1.

Authors:  Aijun Ren; Zhenzhen Wen; Liangjie Zheng
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

Review 3.  Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.

Authors:  Sepideh Mirzaei; Kiavash Hushmandi; Amirhossein Zabolian; Hossein Saleki; Seyed Mohammad Reza Torabi; Adnan Ranjbar; SeyedHesam SeyedSaleh; Seyed Omid Sharifzadeh; Haroon Khan; Milad Ashrafizadeh; Ali Zarrabi; Kwang-Seok Ahn
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.